Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells (original) (raw)

References

  1. Smith M, Luker K, Garbow J, Prior J, Jackson E, Piwnica-Worms D et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004; 64: 8604–8612.
    Article CAS Google Scholar
  2. Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335–348.
    Article CAS Google Scholar
  3. Zou W, Machelon V, Coulomb-L’Hermin A, Borvak J, Nome F, Isaeva T et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001; 7: 1339–1346.
    Article CAS Google Scholar
  4. Lee B, Lee T, Avraham S, Avraham H . Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004; 2: 327–338.
    CAS Google Scholar
  5. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanon M et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–56.
    Article CAS Google Scholar
  6. Jiang Y, Wu X, Shi B, Wu W, Yin G . Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 2006; 103: 226–233.
    Article CAS Google Scholar
  7. Chu Q, Panu L, Holm N, Li B, Johnson L, Zhang S . High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome. J Surg Res 2010; 159: 689–695.
    Article CAS Google Scholar
  8. Akashi T, Koizumi K, Tsuneyama K, Saiki I, Takano Y, Fuse H . Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci 2008; 99: 539–542.
    Article CAS Google Scholar
  9. Konoplev S, Jorgensen J, Thomas D, Lin E, Burger J, Kantarjian H et al. Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia. Cancer 2011 (e-pub ahead of print; doi:10.1002/cncr.26113).
    Article CAS Google Scholar
  10. Busillo J, Benovic J . Regulation of CXCR4 signaling. Biochim Biophys Acta 2007; 1768: 952–963.
    Article CAS Google Scholar
  11. Torisawa Y, Mosadegh B, Bersano-Begey T, Steele J, Luker K, Luker G et al. Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells. Integr Biol 2010; 2: 680–686.
    Article CAS Google Scholar
  12. Allinen M, R B, Cai L, Brennan C, Lahti-Domerci J, Huang H et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17–32.
    Article CAS Google Scholar
  13. Boldajipour B, Mahabaleshwar S, Kardash E, Reichman-Fried M, Blaser H, Minina S et al. Control of chemokine-guided cell migration by ligand sequestration. Cell 2008; 132: 463–473.
    Article CAS Google Scholar
  14. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar S, Raz E, Zerwes H et al. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 2010; 5: e9175.
    Article Google Scholar
  15. Luker K, Steele J, Mihalko L, Luker G . Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010; 29: 4599–4610.
    Article CAS Google Scholar
  16. Luker K, Gupta M, Luker G . Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques 2009; 47: 625–632.
    Article CAS Google Scholar
  17. Albright C, Graciani N, Han W, Yue E, Stein R, Lai Z et al. Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity. Mol Cancer Ther 2005; 4: 751–760.
    Article CAS Google Scholar
  18. Tannous B, Kim D, Fernandez J, Weissleder R, Breakefield X . Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005; 11: 435–443.
    Article CAS Google Scholar
  19. Miao Z, Luker K, Summers B, Berahovich R, Bhojani M, Rehemtulla A et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735–15740.
    Article CAS Google Scholar
  20. Takano S, Yamashita T, Ohneda O . Molecular therapeutic targets for glioma angiogenesis. J Oncol 2010; 2010: 351908.
    Article Google Scholar
  21. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004; 18: 1240–1242.
    Article CAS Google Scholar
  22. Sanchez-Alcaniz J, Haege S, Mueller W, Pla R, Mackay F, Schulz S et al. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 2011; 69: 77–90.
    Article CAS Google Scholar
  23. Wang Y, Li G, Stanco A, Long J, Crawford D, Potter G et al. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 2011; 69: 61–76.
    Article CAS Google Scholar
  24. Song J, Cavnar S, Walker A, Luker K, Gupta M, Tung Y et al. Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One 2009; 4: e5756.
    Article Google Scholar
  25. Salcedo R, Wasserman K, Young H, Grimm M, Howard O, Avnver M et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125–1134.
    Article CAS Google Scholar
  26. Teicher B, Fricker S . CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010; 16: 2927–2931.
    Article CAS Google Scholar
  27. Duda D, Kozin S, Kirkpatrick N, Xu L, Fukumura D, Jain R . CXCL12 (SDF1α) - CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anti-cancer therapies? Clin Cancer Res 2011; 17: 2074–2080.
    Article CAS Google Scholar
  28. Pablos J, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 1999; 155: 1577–1586.
    Article CAS Google Scholar
  29. Karnoub A, Dash A, Vo A, Sullivan A, Brooks M, Bell G et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557–563.
    Article CAS Google Scholar
  30. Zhang X, Wang Q, Gerald W, Hudis C, Norton L, Smid M et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009; 16: 67–78.
    Article CAS Google Scholar
  31. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta K et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283–4294.
    Article CAS Google Scholar
  32. Zabel B, Wang Y, Lewen S, Berahovich R, Penfold M, Zhang P et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009; 183: 3204–3211.
    Article CAS Google Scholar
  33. Hattermann K, Held-Feindt J, Lucius R, Muerkoster S, Penfold M, Schall T et al. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 2010; 70: 3299–3308.
    Article CAS Google Scholar
  34. Lois C, Hong E, Pease S, Brown E, Baltimore D . Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868–872.
    Article CAS Google Scholar
  35. Luker K, Gupta M, Luker G . Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 2009; 23: 823–834.
    Article CAS Google Scholar
  36. Wurdinger T, Badr C, Pike L, de Kleine R, Weissleder R, Breakefield X et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 2008; 5: 171–173.
    Article CAS Google Scholar
  37. Luker G, Pica C, Song J, Luker K, Piwnica-Worms D . Imaging 26S proteasome activity and inhibition in living mice. Nat Med 2003; 9: 969–973.
    Article CAS Google Scholar
  38. Meng H, Chen G, Zhang X, Wang Z, Thomas D, Giordano T et al. Stromal LRP1 in lung adenocarcinoma predicts clinical outcome. Clin Cancer Res 2011; 17: 2426–2433.
    Article CAS Google Scholar

Download references